Logo image of GLAC

GLOBAL LIGHTS ACQUISITION CO (GLAC) Stock Fundamental Analysis

NASDAQ:GLAC - Nasdaq - KYG3937F1019 - Common Stock - Currency: USD

10.77  -0.03 (-0.28%)

Fundamental Rating

1

Taking everything into account, GLAC scores 1 out of 10 in our fundamental rating. GLAC was compared to 0 industry peers in the Unkown industry. GLAC has a bad profitability rating. Also its financial health evaluation is rather negative. GLAC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year GLAC was profitable.
In the past year GLAC has reported a negative cash flow from operations.
GLAC Yearly Net Income VS EBIT VS OCF VS FCFGLAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -500K -1M -1.5M

1.2 Ratios

Industry RankSector Rank
ROA 3.18%
ROE 3.31%
ROIC N/A
ROA(3y)-2.74%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GLAC Yearly ROA, ROE, ROICGLAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 20 40 60 80

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for GLAC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GLAC Yearly Profit, Operating, Gross MarginsGLAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, GLAC has more shares outstanding
GLAC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GLAC Yearly Shares OutstandingGLAC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M
GLAC Yearly Total Debt VS Total AssetsGLAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M

2.2 Solvency

GLAC has an Altman-Z score of 19.30. This indicates that GLAC is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.00 indicates that GLAC is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 19.3
ROIC/WACCN/A
WACCN/A
GLAC Yearly LT Debt VS Equity VS FCFGLAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

GLAC has a Current Ratio of 0.09. This is a bad value and indicates that GLAC is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.09 indicates that GLAC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.09
Quick Ratio 0.09
GLAC Yearly Current Assets VS Current LiabilitesGLAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 200K 400K 600K 800K

1

3. Growth

3.1 Past

GLAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 189.10%, which is quite impressive.
EPS 1Y (TTM)189.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4219.34%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GLAC Yearly Revenue VS EstimatesGLAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023
GLAC Yearly EPS VS EstimatesGLAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 41.42, the valuation of GLAC can be described as expensive.
The average S&P500 Price/Earnings ratio is at 29.62. GLAC is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 41.42
Fwd PE N/A
GLAC Price Earnings VS Forward Price EarningsGLAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GLAC Per share dataGLAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for GLAC!.
Industry RankSector Rank
Dividend Yield N/A

GLOBAL LIGHTS ACQUISITION CO

NASDAQ:GLAC (2/21/2025, 8:23:50 PM)

10.77

-0.03 (-0.28%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners59.49%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap96.61M
Analysts0
Price TargetN/A
Short Float %0.4%
Short Ratio0.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 41.42
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.39
P/tB 1.39
EV/EBITDA N/A
EPS(TTM)0.26
EY2.41%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0
BVpS7.76
TBVpS7.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.18%
ROE 3.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2.74%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.09
Quick Ratio 0.09
Altman-Z 19.3
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)189.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4219.34%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-428.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A